BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25743833)

  • 21. Gastric dysplasia in random biopsies: the influence of
    Ferreira AI; Lima Capela T; Macedo Silva V; Xavier S; Boal Carvalho P; Magalhães J; Cotter J
    Scand J Gastroenterol; 2024; 59(2):125-132. PubMed ID: 37872792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.
    Milito C; Pulvirenti F; Garzi G; Sculco E; Cinetto F; Firinu D; Lagnese G; Punziano A; Discardi C; Costanzo G; Felice C; Spadaro G; Ferrari S; Quinti I
    Front Immunol; 2023; 14():1231242. PubMed ID: 37868983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global knowledge mapping and emerging trends in Helicobacter pylori-related precancerous lesions of gastric cancer research: A bibliometric analysis from 2013 to 2023.
    Xiong M; Yu C; Ren B; Zhong M; Peng Q; Zeng M; Song H
    Medicine (Baltimore); 2023 Dec; 102(48):e36445. PubMed ID: 38050286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time assessment of H. pylori during the endoscopic assessment of individuals with gastric intestinal metaplasia: a possible way to reduce the burden of care.
    Esposito G; Libânio D; Ligato I; Ramos Silva D; Dilaghi E; Ortigão R; Carabotti M; Chaves J; Annibale B; Dinis-Ribeiro M
    Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1154-1158. PubMed ID: 37577819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancer.
    Jencks DS; Adam JD; Borum ML; Koh JM; Stephen S; Doman DB
    Gastroenterol Hepatol (N Y); 2018 Feb; 14(2):92-101. PubMed ID: 29606921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory microenvironment in gastric premalignant lesions: implication and application.
    Zhang S; Shen Y; Liu H; Zhu D; Fang J; Pan H; Liu W
    Front Immunol; 2023; 14():1297101. PubMed ID: 38035066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy.
    Saka A; Yagi K; Nimura S
    Gastric Cancer; 2016 Apr; 19(2):524-530. PubMed ID: 25752268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the relationship between invasive capability of Helicobacter pylori and gastroduodenal diseases.
    Zhang X; Zhang J; Lin Y; Xu K; Li N; Chen H; She F
    J Med Microbiol; 2015 May; 64(Pt 5):498-506. PubMed ID: 25752851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of Helicobacter pylori eradication therapy on the development of gastroesophageal reflux disease.
    Tan J; Wang Y; Sun X; Cui W; Ge J; Lin L
    Am J Med Sci; 2015 Apr; 349(4):364-71. PubMed ID: 25767896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection.
    Ramos-Soriano AG; Black J
    Case Rep Gastroenterol; 2015; 9(1):36-42. PubMed ID: 25759631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors of early proximal gastric carcinoma in Chinese diagnosed using WHO criteria.
    Fang C; Huang Q; Lu L; Shi J; Sun Q; Xu GF; Gold J; Mashimo H; Zou XP
    J Dig Dis; 2015 Jun; 16(6):327-36. PubMed ID: 25754397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of a vitamin D₃ decomposition product bactericidal against Helicobacter pylori.
    Hosoda K; Shimomura H; Wanibuchi K; Masui H; Amgalanbaatar A; Hayashi S; Takahashi T; Hirai Y
    Sci Rep; 2015 Mar; 5():8860. PubMed ID: 25749128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of gastric precancerous lesions among chronic dyspeptic patients and related common risk factors.
    Ajdarkosh H; Sohrabi M; Moradniani M; Rakhshani N; Sotodeh M; Hemmasi G; Khoonsari M; Ameli M; Malekzadeh R; Zamani F
    Eur J Cancer Prev; 2015 Sep; 24(5):400-6. PubMed ID: 25793916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer.
    Park YH; Kim N
    J Cancer Prev; 2015 Mar; 20(1):25-40. PubMed ID: 25853101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylori.
    Jung SW; Thamphiwatana S; Zhang L; Obonyo M
    PLoS One; 2015; 10(3):e0116519. PubMed ID: 25793403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of intestinal metaplasia as a predictor of gastric cancer development.
    Shichijo S; Hirata Y; Sakitani K; Yamamoto S; Serizawa T; Niikura R; Watabe H; Yoshida S; Yamada A; Yamaji Y; Ushiku T; Fukayama M; Koike K
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1260-4. PubMed ID: 25777777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population.
    Song H; Ekheden IG; Zheng Z; Ericsson J; Nyrén O; Ye W
    BMJ; 2015 Jul; 351():h3867. PubMed ID: 26215280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte 'homing' and chronic inflammation.
    Sakai Y; Kobayashi M
    Pathol Int; 2015 Jul; 65(7):344-54. PubMed ID: 25831975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori in Iran: A systematic review on the antibiotic resistance.
    Khademi F; Poursina F; Hosseini E; Akbari M; Safaei HG
    Iran J Basic Med Sci; 2015 Jan; 18(1):2-7. PubMed ID: 25810869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature.
    Campanati A; Ganzetti G; Martina E; Giannoni M; Gesuita R; Bendia E; Giuliodori K; Sandroni L; Offidani A
    Int J Dermatol; 2015; 54(5):e109-14. PubMed ID: 25808243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.